Skip to main content
Livermore
Livermore
ZHEN

SG Americas Securities, LLC

SEC CIK
0001313360
Latest filing
Aug 7, 2026

AXSM holding history

Axsome Therapeutics, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings

Shares (Q2 2026)
2,781
Value
$681.0K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of AXSM by SG Americas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,781$681.0K<0.1%−4,611−62.4%ReducedHolders
Q1 20267,392$1.25M<0.1%−10,289−58.2%ReducedHolders
Q4 202517,681$3.23M<0.1%+5,584+46.2%AddedHolders
Q3 202512,097$1.47M<0.1%+5,368+79.8%AddedHolders
Q2 20256,729$702.0K<0.1%+3,978+144.6%AddedHolders
Q1 20252,751$321.0K<0.1%−801−22.6%ReducedHolders
Q4 20243,552$301.0K<0.1%−8,001−69.3%ReducedHolders
Q3 202411,553$1.04M<0.1%+11,553NewHolders
Q2 20240$00.0%−15,104−100.0%Sold outHolders
Q1 202415,104$1.21M<0.1%+12,963+605.5%AddedHolders
Q4 20232,141$170.0K<0.1%+2,141NewHolders
Q2 20230$00.0%−13,269−100.0%Sold outHolders
Q1 202313,269$818.0K<0.1%+11,561+676.9%AddedHolders
Q4 20221,708$132.0K<0.1%−12,154−87.7%ReducedHolders
Q3 202213,862$619.0K<0.1%+5,412+64.0%AddedHolders
Q2 20228,450$324.0K<0.1%−23,760−73.8%ReducedHolders
Q1 202232,210$1.33M<0.1%−1,033−3.1%ReducedHolders
Q4 202133,243$1.26M<0.1%−49,823−60.0%ReducedHolders
Q3 202183,066$2.74M<0.1%+39,559+90.9%AddedHolders
Q2 202143,507$2.94M<0.1%−10,843−20.0%ReducedHolders
Q1 202154,350$3.08M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.